A recent report from The Nation, authored by Chuck Collins, targets private-equity magnate Jeffrey Leerink, accusing him of engaging in practices that negatively impact the healthcare and life sciences industries. The article frames Leerink’s business model as a form of "plundering," suggesting that his firm’s financial activities prioritize profit extraction over the quality or accessibility of healthcare services.

Because the provided source is an opinion-based critique, there is no counter-narrative or response from Leerink or his firm included in the reporting. The article does not detail specific transactions or provide data to support the claim of "pillaging," but rather presents the characterization as a matter of public interest regarding the influence of private equity in essential services. The report serves as an indictment of the broader private-equity model in medicine, using Leerink as a primary case study for what the author views as systemic exploitation. As this is a single-source report, there are no conflicting accounts of the facts, but the lack of input from the subject or industry experts leaves the allegations unverified by independent parties.